Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ostrong
- Development stage
- Unknown
- Lead developer
- Taj Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Ostrong is a multi-mineral nutritional supplement developed and manufactured by Taj Pharmaceuticals. Formulated as an oral tablet, it contains a combination of calcium, magnesium, and zinc as active ingredients. The product is primarily indicated for the prophylactic treatment of mineral and vitamin deficiency states, particularly during pregnancy and lactation. It is designed to support the development of strong bones and teeth, maintain a regular heartbeat, and reduce the risk of osteoporosis and colon cancer. Additionally, the inclusion of magnesium and zinc assists in preventing muscle cramps and supporting the relaxation of the central nervous system.
- Brand names
- OstrongCalcium Ostrong
Beyond the preview
Go deeper on Ostrong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ostrong.